Monday, October 8, 2018
- 1:15pm-2:45pm
-
Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative
Parkinson's Disease: Cognition · Hall 3FG
- 1:15pm-2:45pm
-
Effect of Glucocerebrosidase enzymatic activity on neural activation during a cognitive task in Parkinson’s disease patients
Parkinson's Disease: Cognition · Hall 3FG
- 1:15pm-2:45pm
-
Effect of levodopa on fronto-parietal network connectivity in freezing of gait in Parkinson’s disease
- 1:15pm-2:45pm
-
Effect of medication on lexical tone production in Cantonese patients with Parkinson’s Disease
Parkinson's Disease: Non-Motor Symptoms · Hall 3FG
- 1:15pm-2:45pm
-
Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease
Parkinson's Disease: Cognition · Hall 3FG
- 1:15pm-2:45pm
-
Effect of Urinary Dysfunction on Fatigue Syndrome in Parkinson’s disease
Parkinson's Disease: Non-Motor Symptoms · Hall 3FG
- 1:15pm-2:45pm
-
Effective Tools for Mild Cognitive Impairment Level I Criteria of Movement Disorder Society: Utility of Screening Tests and Their Interconversion
Parkinson's Disease: Cognition · Hall 3FG
- 1:15pm-2:45pm
-
Effects of age, motor severity and disease duration on finger tapping movement under dual-task in Parkinson’s disease patients
- 1:15pm-2:45pm
-
Effects of computerized cognitive training, with and without concurrent exercise, on executive functions in Parkinson’s disease
Parkinson's Disease: Cognition · Hall 3FG
- 1:15pm-2:45pm
-
Effects of Glial Heme Oxygenase-1 on Neuronal Alpha-Synuclein in the GFAP.HMOX1 Mouse Model of Parkinson’s Disease
Parkinson's Disease: Pathophysiology · Hall 3FG
- «Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 59
- Next Page»